Deep Vein Thrombosis

Clinical Trial Finder

Many patients with deep vein thrombosis are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer

Conditions:   Cancer;   Venous Thromboembolism;   Deep Vein Thrombosis (DVT);   Pulmonary Embolism (PE);   Blood Clot;   VTE
Interventions:   Drug: Rivaroxaban;   Drug: Apixaban;   Drug: Edoxaban;   Drug: Dabigatran;   Drug: Warfarin;   Drug: Dalteparin;   Drug: Enoxaparin;   Drug: Fondaparinux
Sponsors:   Alliance Foundation Trials, LLC.;   Patient-Centered Outcomes Research Institute
Not yet recruiting - verified May 2016

Small Volume Plasma Exchange (SVPE) for Guillain-Barré Syndrome (GBS) Patients

Condition:   Guillain-Barré Syndrome
Intervention:   Procedure: Small Volume Plasma Exchange
Sponsors:   International Centre for Diarrhoeal Disease Research, Bangladesh;   GBS-CIDP Foundation International;   National Institute of Neuroscience, Dhaka, Bangladesh;   Erasmus Medical Center
Recruiting - verified May 2016

A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer

Condition:   Venous Thrombosis and Pulmonary Embolism
Intervention:   Drug: Rivaroxaban (Xarelto, BAY 59-7939)
Sponsors:   Bayer;   Janssen Research & Development, LLC
Not yet recruiting - verified May 2016

Polidocanol Versus Glucose Treatment of Telangiectasia Trial

Conditions:   Varicose Veins;   Telangiectasis
Interventions:   Drug: Glucose;   Drug: Polidocanol with Glucose
Sponsors:   UPECLIN HC FM Botucatu Unesp;   Fundação de Amparo à Pesquisa do Estado de São Paulo
Recruiting - verified May 2016

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes

Condition:   Transcatheter Aortic Valve Replacement
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Acetylsalicylic acid;   Drug: Clopidogrel
Sponsors:   Bayer;   Janssen Research & Development, LLC
Recruiting - verified May 2016

D-dimer Testing Tailored to Clinical Pretest Probability in Suspected Pulmonary Embolism

Condition:   Pulmonary Embolism
Intervention:  
Sponsors:   McMaster University;   Canadian Institutes of Health Research (CIHR)
Recruiting - verified May 2016

: Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery

Conditions:   Venous Thromboembolism;   Pulmonary Embolism;   Thromboprophylaxis
Intervention:   Drug: Enoxaparin
Sponsor:   Tampere University Hospital
Recruiting - verified May 2016

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Standard of care drugs
Sponsor:   Bayer
Recruiting - verified May 2016

Predicting the Safety and Effectiveness of Inferior Vena Cava Filters

Condition:   Pulmonary Embolism
Intervention:   Device: IVC Filter
Sponsors:   New England Research Institutes;   IVC Filter Study Group Foundation (IDE Sponsor);   ALN Implants Chirurgicaux;   B. Braun Interventional Systems, Inc;   Bard Peripheral Vascular, Inc.;   Cook;   Cordis Corporation;   Volcano Corporation;   Rex Medical
Recruiting - verified October 2015

D-dimer and Pre-test Clinical Probability Score in Cancer Patients With Suspected Deep Vein Thrombosis of the Legs

Condition:   Deep Vein Thrombosis
Intervention:   Other: Diagnostic tests for suspected deep vein thrombosis
Sponsor:   G. d'Annunzio University
Recruiting - verified May 2016

Thoracic Surgery Extended Low-Molecular Weight Heparin VTE Prophylaxis--Pilot Trial

Conditions:   Venous Thromboembolism;   Lung Neoplasms;   Pulmonary Embolism
Interventions:   Drug: LMWH: Dalteparin;   Other: Placebo
Sponsors:   McMaster University;   University Health Network, Toronto;   Trillium Health Partners
Recruiting - verified May 2016

AOP2014 in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study.

Condition:   Polycythemia Vera
Intervention:   Drug: Pegylated-Proline-interferon alpha-2b
Sponsors:   AOP Orphan Pharmaceuticals AG;   PharmaEssentia (Co-Sponsor for USA)
Recruiting - verified May 2016

Pre-hospital Anti-fibrinolytics for Traumatic Coagulopathy and Haemorrhage (The PATCH Study)

Conditions:   Wounds and Injuries;   Acute Coagulopathy
Interventions:   Drug: Tranexamic Acid;   Drug: Placebo
Sponsors:   National Trauma Research Institute;   National Health and Medical Research Council, Australia
Recruiting - verified May 2016

Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia

Conditions:   Medical Patient;   Thrombocytopenia
Intervention:   Drug: Fondaparinux
Sponsor:   G. d'Annunzio University
Active, not recruiting - verified May 2016

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

Condition:   Unsuspected Pulmonary Embolism
Intervention:   Drug: Heparin, fondaparinux, vitamin-K antagonists, aspirin
Sponsor:   G. d'Annunzio University
Recruiting - verified May 2016

Point of Care Ultrasound (US) Versus Detailed Radiology US for Deep Vein Thrombosis (DVT)

Condition:   DEEP VEIN THROMBOSIS
Intervention:  
Sponsor:   University of Missouri-Columbia
Withdrawn - verified May 2016

Clinical and Economic Implications of Genetic Testing for Warfarin Management

Condition:   Blood Coagulation Disorders
Intervention:   Drug: Warfarin
Sponsors:   University of Chicago;   Agency for Healthcare Research and Quality (AHRQ)
Active, not recruiting - verified May 2016

Predictors of Anticoagulation Control on Warfarin Therapy

Conditions:   Atrial Fibrillation;   Deep Vein Thrombosis;   Heart Valve Replacement
Intervention:  
Sponsors:   University of Pennsylvania;   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified May 2016

Ultrasound Elasticity Imaging of Venous Thrombi

Condition:   Thrombosis
Interventions:   Procedure: Ultrasound;   Procedure: Ultrasound
Sponsors:   University of Michigan;   National Institutes of Health (NIH)
Completed - verified May 2016

Comparing Total Hip Arthroplasty and Hemi-Arthroplasty on Secondary Procedures and Quality of Life in Adults With Displaced Hip Fractures

Conditions:   Hip Fractures;   Femoral Neck Fractures
Interventions:   Device: Total hip arthroplasty;   Device: Hemi-arthroplasty
Sponsors:   McMaster University;   Canadian Institutes of Health Research (CIHR);   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS);   Hamilton Health Sciences Corporation;   ZonMw: The Netherlands Organisation for Health Research and Development;   Sophies Minde Ortopedi
Recruiting - verified May 2016

Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine Services

Condition:   Thrombosis
Intervention:   Behavioral: Observation
Sponsor:   University of Chicago
Active, not recruiting - verified May 2016